SENOMYX INC Form 8-K: Current report
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2016-12-22: Form 8-K; Period of report 2016-12-21; Description 1.01 Entry into a Material Definitive Agreement; Details 1.01.
- 2016-12-06: Form 8-K; Period of report 2016-12-01; Description 8.01 Other Events; Details 8.01.
- 2016-12-05: Form 8-K; Period of report 2016-12-02; Description 2.05 Costs Associated with Exit or Disposal Activities; 8.01 Other Events; Details 2.05.
- 2016-10-27: Form 8-K; Period of report 2016-10-27; Description 2.02 Results of Operations and Financial Condition; Details 2.02.
| Filed | Form | Period of report | Description | Details | Document |
|---|---|---|---|---|---|
| 2016-12-22 | 8-K | 2016-12-21 | 1.01 Entry into a Material Definitive Agreement | 1.01 Entry into a Material Definitive Agreement. | snmx20161221_8k.htm |
| 2016-12-06 | 8-K | 2016-12-01 | 8.01 Other Events | 8.01 On December 1, 2016, Senomyx and PepsiCo, Inc. executed an amendment to the collaborative research agreement dated April 8, 2014 related to Senomyx’s Salt Taste Program. | snmx20161205_8k.htm |
| 2016-12-05 | 8-K | 2016-12-02 | 2.05 Costs Associated with Exit or Disposal Activities; 8.01 Other Events | 2.05 On December 2, 2016, Senomyx, Inc. (the "Company") implemented a restructuring plan (the “Plan”). 8.01 The Company’s previously announced financial guidance for the fourth quarter of 2016 has not been revised based on the implementation of the Plan. | snmx20161202_8k.htm |
| 2016-10-27 | 8-K | 2016-10-27 | 2.02 Results of Operations and Financial Condition | 2.02 On October 27, 2016, we announced financial results for the quarter ended September 30, 2016 in the earnings release attached hereto as Exhibit 99.1 and incorporated herein by reference. | snmx20161026_8k.htm |
| 2016-09-30 | 8-K | 2016-09-30 | 1.01 Entry into a Material Definitive Agreement | 1.01 On September 30, 2016, we announced that we entered into an Amended and Restated Collaborative Research, Development, Commercialization and License Agreement with PepsiCo, Inc. effective as of September 30, 2016. | snmx20160928_8k.htm |
| 2016-07-28 | 8-K | 2016-07-28 | 2.02 Results of Operations and Financial Condition | 2.02 On July 28, 2016, we announced financial results for the quarter ended June 30, 2016 in the earnings release attached hereto as Exhibit 99.1 and incorporated herein by reference. | snmx20160727b_8k.htm |
| 2016-07-28 | 8-K | 2016-07-28 | 1.01 Entry into a Material Definitive Agreement | 1.01 On July 28, 2016, we entered into a Letter Agreement with PepsiCo, Inc. to extend the research period under our Collaborative Research, Development, Commercialization and License Agreement dated August 16, 2010, as last amended on March 31, 2014, for an additional forty-five (45) days, through September 30, 2016. | snmx20160727_8k.htm |
| 2016-05-24 | 8-K | 2016-05-20 | 5.07 Submission of Matters to a Vote of Security Holders | 5.07 Our 2016 Annual Meeting of Stockholders, or our Annual Meeting, was held on May 20, 2016. | snmx20160523_8k.htm |
| 2016-04-28 | 8-K | 2016-04-28 | 2.02 Results of Operations and Financial Condition | 2.02 On April 28, 2016, we announced financial results for the quarter ended March 31, 2016 in the earnings release attached hereto as Exhibit 99.1 and incorporated herein by reference. | snmx20160426_8k.htm |
| 2016-03-09 | 8-K | 2016-03-06 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | 5.02 On March 6, 2016, Dr. Roger D. Billingsley, a member of our Board of Directors, notified Senomyx, Inc. of his decision to retire and to not stand for re-election at our 2016 Annual Meeting of Stockholders. | snmx20160309_8k.htm |
| 2016-03-03 | 8-K | 2016-03-03 | 2.02 Results of Operations and Financial Condition | 2.02 On March 3, 2016, we announced financial results for the quarter and year ended December 31, 2015 in the earnings release attached hereto as Exhibit 99.1 and incorporated herein by reference. | snmx20160302b_8k.htm |
| 2016-02-26 | 8-K | 2016-02-26 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | 5.02 In February 2016, the Compensation Committee reviewed current base salaries for each of our named executive officers and determined that there would be no increases in base salaries for the named executive officers for 2016 at this time. | snmx20160224_8k.htm |